GIST Cancer UK News
Please see the latest news, research and findings below...
New cancer drug Entrectinib (Rozlytrek) approved for Cancer Drug Fund in England
We are very pleased to hear that NICE has approved the Roche drug Entrectinib (Rozlytrek), for use via the Cancer drug fund (CDF) in England by adults and children 12 years and older, who have advanced NTRK (Neurotrophic Tyrosine Receptor Kinase) fusion-positive solid tumours and no satisfactory treatment options. Eligible patients will have access to […]
Continue reading →VOYAGER Phase 3 clinical trial results…
This week Blueprint Pharmaceuticals announced the results of their Voyager trial which compared AYVAKIT™ (avapritinib) with Regorafenib. The trial did not meet the main aim (or endpoint). As a result they are proposing: To continue promoting avapritinib in the United States for the treatment of adults with unresectable or metastatic PDGFRA exon 18 mutated GIST, including […]
Continue reading →Be a lock down champion for GIST Cancer UK and take part in the Nation’s 2.6 challenge!
On Sunday 26 April the London Marathon was cancelled due to the coronavirus outbreak and it is likely that many other events that would normally involve our fantastic #GISTCANCERUK & #PAWSGIST supporters will also not go ahead this year. So, we are hoping that you can have some fun while in lock down and raise vital […]
Continue reading →New Cancer drug Larotrectinib (Vitrakvi) approved for Cancer Drug Fund in England
We are very pleased to announce that NICE has approved the Bayer drug Larotrectinib (Vitrakvi) for use via the Cancer drug fund (CDF) in England for adults and children who have failed other treatment options and whose tumours test positively for the rare NTRK fusion (Neurotrophic Tyrosine Receptor Kinase fusion). Described as an histology agnostic […]
Continue reading →“The Psychological Effects of Living with a GIST” – Patients’ Meeting (London 2020)
Presentation by GIST patient and clinical psychologist Marion Oliver
“Diet, Exercise & Managing Side Effects”, Patients’ Meeting (London 2020)
Presentation by GIST patient and Vicky Rockingham MBE
Continue reading →“Trials, Tissue Bank & Service Specification” (London, March 2020)
Presentation on by Dr Elena Cogocaru – Royal Marsden, London
Continue reading →Welcome & Introduction, Patients’ Meeting (London 2021)
Welcome to the meeting by our chair, Nic Puntis
Covid-19
The government is advising that people with cancer should be particularly stringent in following social distancing measures. Some people with cancer are more at risk of becoming seriously ill if they contract the COVID-19 infection. We have very little information currently, and consequently you should rigorously follow the social distancing advice. If you live with […]
Continue reading →Latest poster for GCUK / PAWS-GIST funded research…
Funds raised by GIST Cancer UK / PAWS-GIST Supporters help us to stimulate and fund research projects aimed at improving treatments for GIST patients. The poster below was recently presented at the National Cancer Research Institutes conference. It highlights PAWS-GIST research that has been funded by GCUK’s PAWS-GIST research fund. None of this would be […]
Continue reading →